Morgan Stanley Downgrades ResMed (RMD) to Equalweight
Morgan Stanley downgraded ResMed (NYSE: RMD) from Overweight to Equalweight with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
